EVO Evotec SE ADRs

Evotec SE is a drug discovery partnership company providing solutions to pharmaceutical & biotechnology companies, academic institutions as well as foundations, and not-for-profit organizations. The company offers its services in the area of neuronal diseases, diabetes & its complications, pain, inflammation, oncology, infectious diseases, respiratory & fibrosis, rare disease, and women's health. This is an ADR of a company whose stock trades outside of the U.S. as the symbol GY:EVT.

$9.51  -0.18 (-1.81%)
As of 03/24/2023 16:00:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Mid cap
GICS sector:  Consumer Discretionary
Industry:  Drug Manufacturers—Specialty &
Index country:  Germany
Country of incorporation:  
IPO date:  02/05/2004
Outstanding shares:  353,905,306
Average volume:  10,054
Market cap:   $3,427,572,889
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%